Stem Cell Therapeutics (SSS.V) Reorganizes, Names New Management Team
12/7/2011 8:11:09 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces Outcome of End of Phase II Meeting With FDA and Provides a Corporate Update & 2011/12 Milestones
12/27/2010 8:52:56 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces the Issuance of United States Patent Relating to NTx(R)-265
12/9/2010 10:25:58 AM
More...
|
Executive Changes at Stem Cell Therapeutics (SSS.V); Alan Moore Will No Longer Be President and CEO and Allen Davidoff Will Become Chief Scientific Officer
11/30/2010 8:13:48 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces Proceeds From Execution of Warrants
11/3/2010 8:39:27 AM
More...
|
Stem Cell Therapeutics (SSS.V) Receives Request for Full TBI Proposal From the US Dept of Defense
10/13/2010 9:34:06 AM
More...
|
Stem Cell Therapeutics (SSS.V) Receives FDA End of Phase II Meeting Date
10/8/2010 9:11:58 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces Appointment of Chief Financial Officer
10/1/2010 8:41:25 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces the Resignation of a Board of Director
9/15/2010 11:57:38 AM
More...
|
Stem Cell Therapeutics (SSS.V) Announces Completion of Further Analysis of the Modified REGENESIS Stroke Data
9/9/2010 9:08:24 AM
More...
|
|